Background: Clostridium difficile infection is transmitted via spores, and the disease is mediated via secreted toxins. It represents a significant healthcare problem, and clinical presentation can range from asymptomatic carriage to life-threatening pseudomembranous colitis.
Sources of data: publications in the field, with a focus on recent developments and concepts.
Areas of agreement: infection control measures, antibiotic stewardship and current management of the initial episode of C. difficile infection.
Areas of controversy: selection and sequence of interventions for the management of recurrent C. difficile infection; management of persistent carriers of toxigenic C. difficile in patients at high risk of subsequent C. difficile infection.
Growing points: use of faecal microbiota transplantation for recurrent C. difficile infection.
Areas timely for developing research: role of specific microbiota-mediated interventions and vaccination in the treatment and prevention of C. difficile infection.
Keywords: antibiotics; colitis; diarrhoea; microbiota.
© The Author(s) 2019. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.